Our April issue of ‘Deep Dive’ will concentrate on Access and Commercialisation, with a special focus on improving outcomes with digital health and customer experience.
In addition to articles on launch strategies and optimising market access, we’ll also hear from:
The issue will also feature insights from clinical stage gene therapy company bluebird bio, and independent health economist and policy specialist Leela Barham, and we will be presenting expert commentary and key highlights from IQVIA‘s market access summit held in London and eyeforpharma Barcelona, including interviews with Janssen’s Kris Sterkens and LEO Innovation Lab’s John Zibert.
George Underwood – Editor, Deep Dive: Access and Commercialisation
Next issue: Access & Commercialisation (April 2019)
Plus: Improving outcomes with digital health • Customer experience
Catch up on recent issues:
R&D Innovation – February 2019
Disruptive Technologies – January 2019
Digital Health Innovation – A Deep Dive special
Oncology – Reflections on ASCO, June 2018
Future Pharma, May 2018
Patient Centricity, April 2018
Digital, December 2017